Mosquitoes that transmit La Crosse virus disease live in wooded areas in the U.S., mainly in the Upper Midwest, Mid-Atlantic ...

Metabolic syndrome is linked to greater risk of developing young-onset dementia, according to a new study. But there are ...

When you’re in the middle of running, you shouldn’t have to tell yourself your legs work. But when your dad lost control of ...

A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been caught between existing classification systems, marking the first major ...

Corcept sees 40% growth in 2025 revenue with promising trials, expanded patient base, and strong projections. Read my ...

Brenan Cullimore had a rare genetic condition, Brugada syndrome, that led to cardiac arrest. His wife wants to raise ...

A newly identified subtype of Castleman disease will help diagnose and properly treat thousands of patients who have been ...

The treatment strategy for congenital adrenal hyperplasia is burdensome and had not changed in more than 70 years until the ...

The FDA has approved Isturisa (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has not been curative.

Osilodrostat, an oral cortisol synthesis inhibitor, was previously approved for treating adults with Cushing disease, a subtype of Cushing syndrome in which the hypercortisolemia is due to pituitary ...

Italian pharma major Recordati (RECI: MI) today announced that the US Food and Drug Administration (FDA) has approved the supplemental new drug application (sNDA) for Isturisa (osilodrostat) for the ...

Clinicians who are unaware of the pseudocondition may mistake elevated cortisol results for signs of true Cushing syndrome ...